Literature DB >> 23337799

Within-person variability in kidney measures.

Elizabeth Selvin1, Stephen P Juraschek, John Eckfeldt, Andrew S Levey, Lesley A Inker, Josef Coresh.   

Abstract

BACKGROUND: Our objective was to quantify short-term total within-person variability in standard and nontraditional kidney measures using national data. STUDY
DESIGN: Repeated examination study of serum and urine kidney measures. SETTING & PARTICIPANTS: Participants 18 years or older in the Third National Health and Nutrition Examination Survey (NHANES III) who had repeated blood and urine samples collected during visits occurring approximately 18 days apart. MEASUREMENTS: Standardized serum creatinine, standardized cystatin C, β-trace protein (BTP), β(2)-microglobulin (B2M), and urine albumin and creatinine. We calculated the within-person coefficient of variation (CV(w)), which includes both biological and analytical variability. We also evaluated the impact of variability on estimates of the prevalence of reduced estimated glomerular filtration rate and albuminuria.
RESULTS: Serum cystatin C level demonstrated the lowest short-term within-person variability (CV(w) = 6.8%). Serum creatinine and B2M levels (CV(w) = 7.6% and 8.4%, respectively) also had low variability. BTP level had the most variability of the serum markers (CV(w) = 11.6%). As expected, urine albumin and urine creatinine measurements showed high variability (CV(w) >30% for both); however, albumin-creatinine ratio performed much better than either measure alone, with CV(w) of 11.3%. The effect of short-term variability on the prevalence of reduced estimated glomerular filtration rate was moderate, with an ~20% lower prevalence when defined based on single measurements compared to repeated application of the same test approximately 18 days apart. Repeated testing for albuminuria had a larger effect, showing a 33% lower prevalence of albuminuria when repeated testing was applied. LIMITATIONS: Only 2 measurements available. General population with low prevalence of kidney disease.
CONCLUSIONS: Our results suggest that creatinine, cystatin C, and B2M levels have similarly low short-term variability. BTP level was more variable compared with the other serum filtration markers. Urine albumin and creatinine levels were highly variable and may benefit from repeated assessments to reduce the misclassification of albuminuria.
Copyright © 2013 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23337799      PMCID: PMC3628297          DOI: 10.1053/j.ajkd.2012.11.048

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  25 in total

1.  Low-molecular weight proteins as markers for glomerular filtration rate.

Authors:  R P Woitas; B Stoffel-Wagner; U Poege; P Schiedermaier; U Spengler; T Sauerbruch
Journal:  Clin Chem       Date:  2001-12       Impact factor: 8.327

2.  Beta-trace protein in serum: a new marker of glomerular filtration rate in the creatinine-blind range.

Authors:  F Priem; H Althaus; M Birnbaum; P Sinha; H S Conradt; K Jung
Journal:  Clin Chem       Date:  1999-04       Impact factor: 8.327

3.  Estimate of biological variation of laboratory analytes based on the third national health and nutrition examination survey.

Authors:  David A Lacher; Jeffery P Hughes; Margaret D Carroll
Journal:  Clin Chem       Date:  2004-12-08       Impact factor: 8.327

4.  The effects of freeze-thaw on β-trace protein and β2-microglobulin assays after long-term sample storage.

Authors:  Stephen P Juraschek; Josef Coresh; Lesley A Inker; Gregory P Rynders; John H Eckfeldt; Elizabeth Selvin
Journal:  Clin Biochem       Date:  2012-03-09       Impact factor: 3.281

5.  Comparison of measured GFR, serum creatinine, cystatin C, and beta-trace protein to predict ESRD in African Americans with hypertensive CKD.

Authors:  Nrupen A Bhavsar; Lawrence J Appel; John W Kusek; Gabriel Contreras; George Bakris; Josef Coresh; Brad C Astor
Journal:  Am J Kidney Dis       Date:  2011-09-22       Impact factor: 8.860

6.  Molecular characterization of beta-trace protein in human serum and urine: a potential diagnostic marker for renal diseases.

Authors:  A Hoffmann; M Nimtz; H S Conradt
Journal:  Glycobiology       Date:  1997-06       Impact factor: 4.313

7.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

8.  Beta-trace protein, cystatin C, beta(2)-microglobulin, and creatinine compared for detecting impaired glomerular filtration rates in children.

Authors:  Guido Filler; Friedrich Priem; Nathalie Lepage; Pranav Sinha; Ilka Vollmer; Heather Clark; Erin Keely; Mary Matzinger; Ayub Akbari; Harald Althaus; Klaus Jung
Journal:  Clin Chem       Date:  2002-05       Impact factor: 8.327

9.  Highly elevated levels of prostaglandin D synthase in the serum of patients with renal failure.

Authors:  D N Melegos; L Grass; A Pierratos; E P Diamandis
Journal:  Urology       Date:  1999-01       Impact factor: 2.649

10.  Calibration of cystatin C in the National Health and Nutrition Examination Surveys (NHANES).

Authors:  Elizabeth Selvin; Stephen P Juraschek; John Eckfeldt; Andrew S Levey; Lesley A Inker; Josef Coresh
Journal:  Am J Kidney Dis       Date:  2012-11-21       Impact factor: 8.860

View more
  33 in total

1.  Prepregnancy renal function and risk of preterm birth and related outcomes.

Authors:  Ziv Harel; Alison L Park; Eric McArthur; Michelle Hladunewich; Jade S Dirk; Ron Wald; Amit X Garg; Joel G Ray
Journal:  CMAJ       Date:  2020-07-27       Impact factor: 8.262

2.  Circulating Beta-2 Microglobulin and Risk of Cancer: The Atherosclerosis Risk in Communities Study (ARIC).

Authors:  Anna E Prizment; Amy M Linabery; Pamela L Lutsey; Elizabeth Selvin; Heather H Nelson; Aaron R Folsom; Timothy R Church; Charles G Drake; Elizabeth A Platz; Corinne Joshu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-02-05       Impact factor: 4.254

3.  Strategies for assessing GFR and albuminuria in the living kidney donor evaluation.

Authors:  Lesley A Inker; Naya Huang; Andrew S Levey
Journal:  Curr Transplant Rep       Date:  2017-01-29

4.  Associations between blood cadmium concentration and kidney function in the U.S. population: Impact of sex, diabetes and hypertension.

Authors:  Jessica M Madrigal; Ana C Ricardo; Victoria Persky; Mary Turyk
Journal:  Environ Res       Date:  2018-11-06       Impact factor: 6.498

5.  Correlation between trough plasma dabigatran concentrations and estimates of glomerular filtration rate based on creatinine and cystatin C.

Authors:  Paul K L Chin; Daniel F B Wright; Mei Zhang; Mary C Wallace; Rebecca L Roberts; David M Patterson; Berit P Jensen; Murray L Barclay; Evan J Begg
Journal:  Drugs R D       Date:  2014-06

6.  Dietary Habits and Risk of Kidney Function Decline in an Urban Population.

Authors:  Yang Liu; Marie Fanelli Kuczmarski; Edgar R Miller; M Berenice Nava; Alan B Zonderman; Michele K Evans; Neil R Powe; Deidra C Crews
Journal:  J Ren Nutr       Date:  2016-10-19       Impact factor: 3.655

7.  Biological Variability of Estimated GFR and Albuminuria in CKD.

Authors:  Sushrut S Waikar; Casey M Rebholz; Zihe Zheng; Shelley Hurwitz; Chi-Yuan Hsu; Harold I Feldman; Dawei Xie; Kathleen D Liu; Theodore E Mifflin; John H Eckfeldt; Paul L Kimmel; Ramachandran S Vasan; Joseph V Bonventre; Lesley A Inker; Josef Coresh
Journal:  Am J Kidney Dis       Date:  2018-07-18       Impact factor: 8.860

8.  Short-term Variability of Vitamin D-Related Biomarkers.

Authors:  Pamela L Lutsey; Christina M Parrinello; Jeffrey R Misialek; Andy N Hoofnagle; Clark M Henderson; Thomas J Laha; Erin D Michos; John H Eckfeldt; Elizabeth Selvin
Journal:  Clin Chem       Date:  2016-09-30       Impact factor: 8.327

9.  Comparison of serum concentrations of β-trace protein, β2-microglobulin, cystatin C, and creatinine in the US population.

Authors:  Stephen P Juraschek; Josef Coresh; Lesley A Inker; Andrew S Levey; Anna Köttgen; Meredith C Foster; Brad C Astor; John H Eckfeldt; Elizabeth Selvin
Journal:  Clin J Am Soc Nephrol       Date:  2013-01-18       Impact factor: 8.237

10.  False-Positive Rate of AKI Using Consensus Creatinine-Based Criteria.

Authors:  Jennie Lin; Hilda Fernandez; Michael G S Shashaty; Dan Negoianu; Jeffrey M Testani; Jeffrey S Berns; Chirag R Parikh; F Perry Wilson
Journal:  Clin J Am Soc Nephrol       Date:  2015-09-03       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.